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A key event in the pathogenesis of Alzheimer’s disease (AD) is the deposition of senile plaques consisting
largely of a peptide known as b-amyloid (Ab) that is derived from the amyloid precursor protein (APP). A
proteolytic activity called c-secretase cleaves APP in the transmembrane domain and is required for Ab
generation. Aberrant c-secretase cleavage of APP underlies the majority of early onset, familial AD.
c-Secretase resides in a large multi-protein complex, of which Presenilin, Nicastrin, APH-1 and PEN-2 are four
essential components. Thus, identifying components and pathways by which the c-secretase activity is
regulated is crucial to understanding the mechanisms underlying AD pathogenesis, and may provide new
diagnostic tools and therapeutic targets. Here we describe the generation of Drosophila that act as living
reporters of c-secretase activity in the ﬂy eye. In these reporter ﬂies the size of the eye correlates with the
level of endogenous c-secretase activity, and is very sensitive to the levels of three genes required for APP
c-secretase activity, presenilin, nicastrin and aph-1. Thus, these ﬂies provide a sensitized system with which
to identify other components of the c-secretase complex and regulators of its activity. We have used these
ﬂies to carry out a screen for mutations that suppress c-secretase activity and have identiﬁed a small
chromosomal region that contains a gene or genes whose products may promote c-secretase activity.
INTRODUCTION
Alzheimer’s disease (AD) is a neurodegenerative disease of
the brain that manifests as a decline of memory and other
cognitive functions. A critical pathogenic event leading to AD
is the progressive accumulation of amyloid plaques consisting
primarily of the amyloid b peptide (Ab) (reviewed in 1,2). Ab
is derived from the amyloid precursor protein (APP), a type 1
transmembrane protein, through the action of two proteolytic
activities known as b-secretase and g-secretase (Fig. 1A). The
sequential action of b-secretase, which cleaves APP in the
extracellular domain, and g-secretase, which cleaves APP
within the transmembrane domain, generates Ab peptides and
releases the intracellular domain of APP (AICD) from
membrane association (Fig. 1A, reviewed in 1–4). g-
Secretase generates two major Ab peptides of 40 or 42–43
residues in length, differing in the length of their C-termini.
The longer forms of Ab, Ab42–43, are prone to aggregate
and are thought to seed the formation of amyloid plaques
(reviewed in 3–5). Understanding how g-secretase-mediated
APP cleavage is achieved is crucial to understand AD
pathogenesis. g-Secretase also cleaves other signaling proteins
within their transmembrane domains (reviewed in 6). One of
the most notable ones is Notch, a key transmembrane receptor
that plays important roles in cell–cell communication both
during development and in adulthood (reviewed in 7). Cleavage
of Notch by g-secretase is essential for Notch function and this
function of g-secretase is evolutionarily conserved (6,7).
g-Secretase activity resides in a large multi-protein complex
(8), the exact molecular weight and composition of which is
still being elucidated (reviewed in 9,10). Recent observations
indicate that the activity of four proteins, Presenilin, Nicastrin,
APH-1 and PEN-2, are necessary for g-secretase activity
(reviewed in 10). The human genome encodes two Presenilins,
Presenilin 1 (PS1) and Presenilin 2 (PS2). Presenilins bind APP
and probably provide the active catalytic core of g-secretase or
act as intimate cofactors (reviewed in 2,6,11–14). Mutations in
PS1 and PS2 are associated with the majority of familial AD
cases (4). Nicastrin is a transmembrane glycoprotein isolated
via its ability to bind PS1 (15) and to promote Notch signaling
*To whom correspondence should be addressed. Tel: þ1 3102067597; Fax: þ1 3102069406; Email: mingfly@ucla.edu
Human Molecular Genetics, 2003, Vol. 12, No. 20 2669–2678
DOI: 10.1093/hmg/ddg292
Human Molecular Genetics, Vol. 12, No. 20 # Oxford University Press 2003; all rights reserved
in C. elegans (16). APH-1, a polytopic membrane protein
originally identified as a regulator of Notch signaling in
C. elegans (17,18), binds to Presenilins and Nicastrin (19–21).
PEN-2, a small protein that spans the membrane twice, was
also first identified as a regulator of Notch signaling in
C. elegans (18). These four proteins, when coexpressed in
S. cerevisiae, which lacks endogenous g-secretase activity, are
sufficient to create an active g-secretase complex (22; reviewed
in 10). This finding suggests that these four proteins are the
minimal core components of the g-secretase, although it does
not exclude the possibility that factors in yeast may also
contribute to formation of the active g-secretase complex.
These four proteins regulate the stability and maturation of
each other in tissue culture (19–26). How this regulation occurs
is unknown. It is also unknown if other signaling pathways
regulate g-secretase activity by modifying the assembly or
activity of these proteins.
Drosophila g-secretase and its four known components are
functionally conserved. Drosophila has an endogenous
g-secretase activity for APP and Notch (27), and its mechanism
of action through formation of a high molecular weight
complex with Presenilin is also conserved (28). Drosophila has
a single homolog each of presenilin (psn) (29–31), nicastrin
(nct) (32–34), aph-1 and pen-2 (18). Loss of psn or nct function
in Drosophila results in Notch-like phenotypes (32–37).
Removing aph-1 or pen-2 in Drosophila Schneider 2 (S2)
culture cells via RNA interference (RNAi) suppresses g-
cleavage of both APP and Notch (18). Together, these
observations indicate that the mechanisms by which APP
cleavage occurs in flies, as well as the pathways by which this
activity is regulated, are conserved with those of mammals.
Genes that regulate g-cleavage of APP have been isolated
successfully through several approaches. Positional cloning of
familial AD genes resulted in identification of PS1 and PS2.
Biochemical purification of PS1-associated proteins led to the
identification of Nicastrin (reviewed in 3–5). Function-based
in vivo genetic screens conducted in model systems such as
C. elegans and Drosophila for phenotypes that are suggestive
of an alteration in g-secretase activity provide an important
complementary strategy for identifying new genes regulating
g-secretase. For example, screens for C. elegans mutants with
Notch-like or presenilin-like developmental defects identified
the g-secretase regulators aph-2 (nicastrin) (16), aph-1 and
pen-2 (17,18). The advantage of the in vivo genetic approach is
Figure 1. A fly eye-based reporter for g-secretase activity. (A) A schematic illustration of APP cleavage sites. The sequential action of b-secretase, which cleaves
APP in the extracellular domain (ECD), and g-secretase, which cleaves APP within the transmembrane domain (TMD), generates Ab. (B) Schematic illustrating a
g-secretase reporter. The reporter contains two components: a chimeric protein, APP-GAL4, as a substrate and the UAS-GRIM construct as an output. APP-GAL4
is specifically expressed in the eye. In the absence of g-secretase mediated APP cleavage (left panel), no cell death will be observed in vivo. In the presence of
g-secretase (right panel), the unleashed APP fragment and GAL4 are translocated to the nucleus and activate GRIM-dependent cell death. (C–F) Scanning electron
micrographs of adult fly eyes of various genotypes. The genotypes are as follows: (C) GMR–APP–GAL4/þ; (D) UAS–GRIM/þ; (E) GMR–APP–GAL4, UAS–
GRIM/þ; (F) GMR–p35/þ; GMR–APP–GAL4, UAS–GRIM/þ. Expression of GMR–APP–GAL4/þ (C) or UAS–GRIM/þ (D), in isolation resulted in flies with
wildtype-appearing eyes. In contrast, Expression of both GMR–APP–GAL4 and UAS–GRIM (reporter) results in adult flies with small eyes (E), indicative of
retinal cell death. Retinal cell death present in the reporter flies is eliminated and eye size restored to normal by coexpression of the caspase inhibitor
baculovirus p35 (F).
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that it does not rely on direct physical binding to existing
proteins such as Presenilins, and thus will not be limited by the
low affinity or abundance of important interacting components.
In addition, it has the potential to identify components of the
regulatory pathways of g-secretase activity that may not bind to
Presenilin. Below, we describe a reporter that allows determi-
nation of the endogenous levels of g-secretase activity in an
easy to visualize, nonessential neuronal tissue, the adult fly eye.
This reporter is designed to identify changes in g-cleavage of
APP. This is in contrast to previous C. elegans and Drosophila-
based screens which used presenilin and Notch mutant
phenotypes during development as surrogate markers
(16–18). In addition, we describe results from a screen utilizing
these flies that identified a small region on the second
chromosome containing one or more genes whose products
may promote APP g-secretase activity.
RESULTS
A reporter for APP c-secretase activity in living flies
As outlined in Figure 1B, we generated transgenic flies
expressing a chimeric type-1 transmembrane protein that
serves as a g-secretase substrate. The N-terminus of the protein
has a cleavable signal sequence which is followed by a
fragment of human APP just C-terminal to the b-secretase
cleavage site. The yeast transcription factor GAL4 is appended
to the APP C-terminus. This protein, known as APP–GAL4, is
targeted to the secretory pathway by the N-terminal signal
sequence. Cotranslational cleavage of this signal sequence as
APP is inserted into the membrane generates a protein that is
C-terminal to the b-secretase cleavage site. We specifically
expressed APP–GAL4 in the eye under the control of the eye-
specific GMR promoter (38). The reporter flies also carry a
g-secretase reporter output construct that consists of a GAL4-
responsive transcriptional cassette driving the expression of the
Drosophila cell death activator GRIM (39). In the absence of
g-secretase, GAL4 remains tethered at the membrane and
therefore is unable to enter the nucleus and activate transcrip-
tion. In the presence of g-secretase activity, cleavage of APP
releases from the membrane a fragment consisting of the
intracellular domain of APP (AICD) and GAL4. This fragment
migrates to the nucleus and activates GRIM transcription,
thereby promoting cell death in the eye (Fig. 1B). Cells and
organisms that act as reporters for caspase family proteases, as
well as Notch or APP g-secretase activity, have been generated
previously (40–43). In these reporters a proteolytic cleavage
event is linked to the transcriptional activation of a reporter
such as LacZ or luciferase. Our strategy utilizes retinal cell
death as a readout to generate a visible and quantifiable eye
phenotype in living animals, and hence facilitates in vivo
genetic screens.
Flies expressing GMR–APP–GAL4 alone have wildtype-
appearing eyes (Fig. 1C), as do flies carrying only UAS–GRIM
(Fig. 1D). In contrast, flies expressing both GMR–APP–GAL4
and UAS–GRIM (referred to hereafter as the reporter flies)
have small eyes (Fig. 1E). Importantly, the reporter small eye
phenotype was completely suppressed when reporter flies also
expressed under GMR control the potent cell death and caspase
inhibitor baculovirus p35 (38) (Fig. 1F), or the Drosophila cell
death and caspase inhibitor DIAP1 (44) (data not shown).
These observations indicate that the reporter small eye
phenotype is strictly due to GRIM-induced caspase-dependent
cell death, and not the result of developmental defects or the
activation of other signal transduction pathways by the cleaved
APP–GAL4 reporter protein.
The g-secretase reporter flies act as a useful genetic
background in which to carry out screens for g-secretase
regulators (see below). Any screen, genetic or chemical,
generates false positives, i.e. mutations that act as modifiers
but that are not interesting for the project at hand. In our case
sources of such modifiers include mutations that affect the
efficiency of GMR- or GAL4-dependent transcriptional
activation, or the efficacy of GRIM-dependent cell death
signaling. We intended to use GMR–GAL4, UAS–GRIM to
eliminate these false positives. However, since GMR–GAL4,
UAS–GRIM flies are lethal, we chose to utilize two strains of
flies that act as reporters for false positives. The first strain is
GMR–GRIM which expresses GRIM directly under GMR
control and has small eyes (Fig. 2D). The second strain is
GMR-GAL4, UAS-GRIM G/REAPER (45). This chimeric
protein, G/REAPER, has the N-terminus of Grim, and the
C-terminus of a second cell death activator, Reaper (Rpr) (46).
GMR–GAL4, UAS–G/RPR flies also have a small eye
phenotype, due to induction of caspase-dependent cell death
(45) (Fig. 2G). True modifiers of g-secretase activity should
alter the eye size of reporter flies, but not those of the false
positive reporter flies. False positives, on the other hand, should
modify eye size similarly in the presence of both the reporter
and false positive reporters. As an example of the latter,
reduction in the levels of glass, which encodes a transcription
factor that drives GMR-dependent expression (47), results
in suppression of the small eye phenotype of reporter
flies, as well as those of the false positive reporters (data not
shown).
Activity of the reporter depends on Presenilin,
Nicastrin and Aph-1
Presenilin, Nicastrin and Aph-1 are required for g-secretase-
dependent cleavage of APP in mammals and Drosophila
(reviewed in 10,14). Thus an important prediction is that the
eye phenotype of reporter flies, but not those of the false
positive reporter flies (GMR–GRIM or GMR–GAL4, UAS–G/
RPR), should be sensitive to the levels of Psn, Nct and Aph-1.
We used two approaches to decrease Psn levels: in the first we
made reporter flies heterozygous for a psn null mutation, psnC1
(35), thereby decreasing the psn genetic dose by 50%; in the
second we generated and expressed a dominant negative
version of Drosophila Psn under GMR control (GMR–PSNDN
flies; see Materials and Methods for details). Heterozygous flies
for psnC1 or GMR–PSNDN alone had wild-type-appearing
eyes (data not shown). In contrast, decreasing Psn levels
suppressed the small eye phenotype of the reporter (Fig. 2B
and C; cf. A), but not the small eye phenotypes associated with
GMR-GRIM (Fig. 2E and F; cf. D) or GMR–GAL4, UAS–G/
RPR (Fig. 2H and I; cf. G).
Results of a similar series of experiments showed that the
reporter eye phenotype was also sensitive to levels of a second
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component of the g-secretase complex, Nct (Fig. 3). Again, we
used two approaches to reduce the levels of Nct. In the first we
made reporter flies heterozygous for a nct null allele, nct J2
(33), thereby decreasing the nct genetic dose by 50%. In the
second we generated flies that expressed an nct RNA
interference construct under GMR control (GMR–RNAi–nct
flies, see Materials and Methods for details), and introduced
these into the reporter background. Heterozygous flies for nct J2
or GMR–RNAi–nct, in isolation, had wild-type-appearing eyes
(data not shown). However, they both led to a strong
suppression of the reporter-dependent small eye phenotype
(Fig. 3B and C; cf. A). As with psn above, reduction of nct
dose had no effect on the eye size of the false positive reporter
flies, GMR–GRIM (Fig. 3E and F; cf. D) and GMR–GAL4,
UAS–G/RPR (Fig. 3H and I; cf. G).
Aph-1 is a third conserved protein that is required for
g-secretase activity. Mutations in Drosophila aph-1 are not
available. Therefore, to determine if loss of aph-1 function
suppressed the reporter small eye phenotype we generated flies
that expressed an aph-1 RNAi construct under GMR control
(GMR-RNAi-aph-1 flies). These flies were wild-type in
appearance (data not shown). They acted as strong suppressors
of the small eye phenotype of the reporter (Fig. 4B), but not
that of the false positive reporters, GMR–GRIM (Fig. 4D) and
GMR–GAL4, UAS–G/RPR (Fig. 4F). Thus, the g-secretase
reporter fly eye phenotype is sensitive to small changes
(roughly 2-fold) in the levels of three known components or
regulators of the g-secretase complex, Psn, Nct and Aph-1.
These observations argue that GMR–APP–GAL4/UAS–GRIM
flies function as reporters of endogenous g-secretase activity
Figure 2. g-Secretase reporter flies are sensitive to the levels of Psn. Scanning electron micrographs of various genotypes are shown. The genotypes are as follows:
(A) GMR–APP–GAL4, UAS–GRIM/þ; (B) GMR–APP–GAL4, UAS–GRIM/þ; psnC1/þ; (C) GMR–APP–GAL4, UAS–GRIM/þ; GMR–PSNDN/þ; (D) GMR–
GRIM/þ; (E) GMR–GRIM/þ; psnC1/þ; (F) GMR–GRIM/þ; GMR–PSNDN/þ; (G) GMR–GAL4, UAS–G/RPR/þ; (H) GMR–GAL4, UAS–G/RPR/þ; psnC1/þ;
(I) GMR–GAL4, UAS–G/RPR/þ; GMR–PSNDN/þ. (A) is identical to Figure 1E, as the crosses for Figures 1–3 were set up in parallel. Decreasing Psn levels
suppress the GMR–APP–GAL4, UAS–GRIM-dependent small eye phenotype (B, C; cf. A), but not the small eye phenotypes associated with GMR-GRIM (E, F;
cf. D) or GMR–GAL4, UAS–G/RPR (H, I; cf. G).
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and that they constitute a sensitized background in which to
screen for g-secretase regulators and components.
The 23C1-3 region contains potential regulators of
c-secretase activity
We carried out a genetic screen for suppressors of APP
g-secretase activity in Drosophila. We screened the second
chromosome using a publicly available ‘deficiency kit’ that
contains 85 stocks that in total delete about 80% of this
chromosome, which makes up about two-fifths of
the Drosophila genome. Heterozygous deletion-bearing flies
were crossed to the reporter flies and progeny bearing the
deletion and reporter identified. These were then scored for
suppression as compared to flies carrying the reporter alone.
Several regions that contained strong suppressor activity were
identified (Table 1). One of these, at 55A-55F, defined by
Df(2R)1547, contains the pen-2 gene (55C1-5) which encodes
the fourth component of mammalian and Drosophila g-secre-
ase complex. A second strong suppressor region was identified
at 23A1-C5, as defined by the deficiency Df(2L)90 (Fig. 5A
and C). This region contains aph-1 (23A6). Df(2L)3910
(23A6-B1) also removes aph-1. This deficiency acted as a
reporter suppressor, but a much weaker one than Df(2L)90
(Fig. 5D). This suggested that the region deleted by Df(2L)90
contains additional g-secretase suppressor loci. We used
smaller deficiencies in the region to further map the suppressor
activity. Df(2L)97 (23C3–D2), Df(2L)4954 (23D2–23E3) and
Figure 3. g-Secretase reporter flies are sensitive to the levels of nct. Scanning electron micrographs of various genotypes are shown. The genotypes are as follows:
(A) GMR–APP–GAL4, UAS–GRIM/þ; (B) GMR–APP–GAL4, UAS–GRIM/þ; nctJ2/þ; (C) GMR–APP–GAL4, UAS–GRIM/þ; GMR–RNAi-nct/þ; (D)
GMR–GRIM/þ; (E) GMR–GRIM/þ; nct J2/þ; (F) GMR–GRIM/þ; GMR–RNAi-nct/þ; (G) GMR–GAL4, UAS–G/RPR/þ; (H) GMR–GAL4, UAS–G/RPR/
þ; nct J2/þ; (I) GMR–GAL4, UAS–G/RPR/þ; GMR–RNAi-nct/þ. (A) is identical to Figures 1E and 2A, (D) is identical to Figure 2D, and (G) is identical
to Figure 2G as the crosses for Figures 1–3 were set up in parallel. Decreasing nct levels suppresses the GMR–APP–GAL4, UAS–GRIM-dependent small eye
phenotype (B, C; cf. A), but not the small eye phenotypes associated with GMR-GRIM (E, F; cf. D) or GMR–GAL4–UASG/RPR (H, I; cf. G).
Human Molecular Genetics, 2003, Vol. 12, No. 20 2673
Df(2L)6875 (23C5–23E2) did not suppress the reporter
phenotype. However, Df(2L)1567, which deletes from 23C1–
E2 and does not overlap with Df(2L)3910, acted as a very
strong reporter suppressor (Fig. 5E). Df(2L)1567 did not
suppress the small eye phenotypes of the two false positive
reporter lines, GMR–GRIM and GMR–GAL4, UAS–G/RPR
(Fig. 5G and I). Together, these observations place the
suppressor in the 23C1–3 region. Based on current annotations
from the Berkeley Drosophila Genome Project (BDGP), this
region spans roughly 150 kb, and contains 10–15 annotated
genes.
The above observations are consistent with the hypothesis
that this region contains a gene(s) that promote g-secretase
activity. However, we cannot exclude the possibility that the
modifier functions instead to regulate the fate of the AICD, to
which GAL4 is appended (see also the Discussion below). This
possibility is not uninteresting. AICD has been shown to
interact with a number of proteins, and evidence suggests that it
can participate in multiple cell-biological processes (reviewed
in 9,48). Once the responsible modifier gene is identified, cell
culture-based assays using RNAi interference to follow AICD
processing and fate in the absence of this gene (18) will
distinguish these possibilities.
DISCUSSION
Mutations in three genes, Presenilin 1, Presenilin 2 and APP
result in early-onset AD, while a polymorphism in APOE4 is
associated with increased susceptibility to late onset AD.
However, these genes are thought to account for as little as 30%
of the genetic variance in AD susceptibility (5), indicating
important regulators remain to be identified. Because the
pathogenesis of AD results from increased deposition of Ab, it
seems likely that components or regulators of g-secretase
activity are among these.
Here we described the generation of flies that function as
living reporters for APP g-secretase activity. In these flies,
g-secretase-dependent cleavage of an APP-tethered transcrip-
tion factor (a protease substrate), expressed specifically in the
developing eye, leads to transcriptional activation of a cell
death activator, Grim. Thus, the levels of endogenous
g-secretase activity are read out as a function of Grim-
dependent cell death, which manifests itself as flies that have
decreased eye size. The Drosophila eye is particularly useful as
a screening system for regulators of g-secretase activity since
its cell population is dominated by neurons, and the eye is
dispensable for viability and fertility. Importantly, the reporter
small eye phenotype is easily quantifiable, and is regulated in a
dose-dependent manner by modest changes (roughly 2-fold)
in the levels of psn, nct and aph-1, which encode known
components of the g-secretase-containing complex. Thus, these
flies constitute a very sensitized background in which to carry
out genetic screens for other regulators of g-secretase activity.
It is important to point out that it is not surprising that modest
changes in the levels of g-secretase components (2-fold
reductions associated with heterozygosity) alter the reporter
eye phenotype, but have no effect on g-secretase-dependent
Figure 4. g-Secretase reporter flies are sensitive to the levels of aph-1.
Scanning electron micrographs of various genotypes are shown. The genotypes
are as follows: (A) GMR–APP–GAL4, UAS–GRIM/þ; (B) GMR–APP–
GAL4, UAS–GRIM/þ; GMR–RNAi-aph-1; (C) GMR–GRIM/þ; (D) GMR–
GRIM/þ; GMR–RNAi–aph-1/þ; (E) GMR–GAL4, UAS–G/RPR/þ; (F)
GMR–GAL4, UAS–G/RPR/þ; GMR–RNAi–aph-1/þ. Decreasing aph-1
levels suppress the GMR–APP–GAL4, UAS–GRIM-dependent small eye
phenotype (B; cf. A), but not the small eye phenotypes associated with
GMR–GRIM (D; cf. C) or GMR–GAL4, UAS–G/RPR (F; cf. E).
Table 1. Summary of the suppressors of reporter eye phenotype identified
in second chromosome deficiencies. The map positions are based on information
provided by Flybase at: http://flystocks.bio.indiana.edu/df-2.htm, updated on
August 1, 2003. The strength of the suppression for each deficiency is listed, with
the number of ‘þ’ indicating the strength (þþþþ being the strongest).
Deficiency Map position Effects on reporter Strength
Df(2L)3548 21B8–C1; 21C8–D1 Suppression þþ
Df(2L)90 23A1–2; 23C3–5 Suppression þþþþ
Df(2L)3910 23A6; 23B1 Suppression þþ
Df(2L)1567 23C1–2; 23E1–2 Suppression þþþ
Df(2R)1547 55A; 55F Suppression þþþ
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developmental processes in the eye, such as Notch signaling.
Our reporter is specifically designed to be sensitive to, and to
be able to report on, levels of g-secretase activity within the
normal physiologic range. Thus, the reporter flies have been
engineered to display a dominant eye phenotype in response to
wild-type levels of g-secretase activity. This is brought about in
several different ways. The reporter protein contains an
N-terminal signal sequence that is removed cotranslationally,
generating a protein that has the N-terminus of b-secretase-
cleaved APP. Therefore, in contrast to endogenous substrates,
the reporter protein does not require a-or b-secretase cleavage
in order to become a suitable substrate for g-secretase. To
the extent that these prior cleavage events are rate-limiting, the
reporter will become the preferred substrate. In addition, in
the reporter flies APP–GAL4 is expressed at high levels,
probably much higher than those of endogenous g-secretase
substrates such as Notch. Therefore, it is likely that the reporter
protein becomes, on a molar basis, the dominant substrate.
Finally, the output of our reporter, cell death in the eye, requires
GAL4-dependent transcriptional activation from the UAS–
GRIM element. Five optimized GAL4 binding sites are present
in this construct (49), thereby conferring a significant level of
transcription-dependent amplification. In this sensitized back-
ground modest changes in the level of g-secretase activity
brought about by changes in the levels of its components would
be expected to result in modification of the eye phenotype. In
contrast to this engineered situation, heterozygosity for almost
all genes in the fly genome (including psn, nct, and aph-1) does
Figure 5. The 23C1-3 region contains a potential regulator of g-secretase activity. (A) Schematic drawings of the chromosomal region 23A–E on the left arm of the
second chromosome (2L) (the solid black bar). The deficiencies utilized in crosses are indicated on the left. Regions deleted are indicted by gaps in the bars. The
location of Aph-1 is indicated by the asterisk. The strength of reporter suppression for each deficiency is indicated to the right, with (þþþþ) being the strongest
(see also C). The boundaries of the 23C1-3 region identified as containing a suppressor are indicated by the dashed vertical lines. (B–E) Representative scanning
electron micrographs of fly eyes of different genotypes. Df(2L)90 results in very strong suppression of the GMR–APP–GAL4, UAS–GRIM small eye phenotype
(C, cf. B). Df(2L)3910, a much smaller deficiency that deletes Aph-1, results in weaker suppression (D). Df(2L)1567, which does not include Aph-1, also results in
suppression of the GMR–APP–GAL4, UAS–GRIM small eye phenotype (E). Df(2L)1567 does not suppress GMR–GRIM (G, cf. F) or GMR–GAL4, UAS–G/
RPR (I, cf. H). Together these observations are consistent with the hypothesis that the 23C1–3 region contains a gene(s) that promotes g-secretase activity.
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not result in observable phenotypes during normal develop-
ment because the residual 50% gene activity is sufficient to
mediate normal signaling within and between cells. In other
words, endogenous cellular signaling pathways such as Notch
are normally buffered against phenotypic variability in
response to modest changes in the activity of genes required
for Notch processing (reviewed in 50).
The g-secretase reporter flies were designed to identify
factors that regulate g-secretase cleavage. However, it is
important to note that several other sorts of interesting
modifiers may be identified. These include factors that
influence the stability and subcellular localization of APP–
GAL4, AICD and g-secretase components. They could also
include factors that regulate proteolysis of the reporter outside
the g-secretase target site. In particular, regulators of a recently
identified e-cleavage which is C-terminal to the g-cleavage site
and is also regulated by Psn (51–54) may also be detected.
Many of these factors would be of potential relevance to the
understanding of Alzheimer’s disease mechanisms.
This reporter has several advantages for conducting genome-
wide genetic screens. First, the small eye phenotype of the
reporter flies acts as a readout of the endogenous, physiological
levels of g-secretase. This stands in contrast to the situation
with many eye-based dominant modifier screens, in which
the sensitized background results from hyperactivation of a
signaling pathway (55). Thus modification of the reporter small
eye phenotype by genetic manipulations or chemical com-
pounds directly reflects modifications of the endogenous,
physiologically relevant level of g-secretase activity. Second,
this reporter allows us to conduct screens that are focused
specifically on identifying genes that regulate cleavage of APP.
It makes no assumption about the role of psn in g-secretase
function, and thus constitutes an unbiased approach to
identifying factors regulating APP processing. Again, this
stands in contrast to screens focused on identifying genes that
use Notch or psn loss-of-function phenotypes during develop-
ment as a surrogate marker. Third, the sensitivity of the reporter
allows us to conduct F1-dominant modifier screens. Since a
large number of flies can be screened in a short period of time
(F1, first generation), this sets the stage for a genome-wide
search for mutations affecting g-secretase. Moreover, disrup-
tion of one copy of almost all genes in the fly genome leads to
flies that are viable and fertile. Thus, a function of these genes
can be tested for even though homozygous deletion of the gene
might be lethal earlier in development. Finally, the reporter flies
are also useful for exploring the roles of candidate genes in
g-secretase regulation. In particular, the fact that levels of
specific genes in the eyes of reporter flies can be selectively
decreased using GMR-RNAi constructs, as illustrated here for
nct and aph-1, provides a rapid method to test candidate
g-secretase regulators in a neural tissue in vivo.
MATERIALS AND METHODS
Constructs and transgenes
The APP–GAL4 coding sequence contains a cleavable signal
sequence followed by a C-terminal fragment of human APP
(56) that initiates immediately downstream of b-cleavage site,
residue 671, and that also lacks a stop codon. GAL4 (57), was
appended to the C-terminus of APP, generating APP–GAL4.
Residue D278 in Drosophila Psn corresponds to one of two
evolutionarily conserved aspartate residues located in putative
transmembrane domains 6 and 7 (29). Mutation of either of
these conserved residues to alanine in mammalian PS1 creates
a protein with dominant negative activity (58). We generated a
dominant negative version of Drosophila Psn (Psn-D278A)
from a psn cDNA, LD25307, obtained from Research
Genetics, using the Stratagene QuikChange Site-Directed
Mutagenesis Kit. Psn-D278A was introduced into the GMR
vector, generating GMR–Psn–D278A.
GMR-driven nct and aph-1 RNAi constructs were generated
following a strategy that results in transcription of sense and
antisense strands of a transgene expressed under GMR control
(59). A similar strategy has been developed to drive double-
stranded RNA production under UAS control (60). A fragment of
Drosophila nct (coding region residues 291–696) or aph-1
(coding region amino acid residues 29–174) was introduced
between two GMR promoter sequences oriented in opposite
directions in the vector PCasper, generating GMR-RNAi-nct and
GMR-RNAi-aph-1, respectively. To ensure that the RNAi effect
was specific to the transgene in question, transgenic flies
containing GMR–RNAi–nct, which suppresses the small eye
phenotype of the GMR–APP–GAL4, UAS–GRIM reporter, were
crossed to flies with small eyes due to expression of GMR–GRIM,
GMR–REAPER (RPR) or GMR–HID (44,61). The small eye
phenotypes of these flies was not suppressed (data not shown).
Transformants were generated using standard microinjection
(62) procedures in 0–1 h w1118 embryos. Multiple transgenic
lines were obtained in each microinjections. For each experi-
ment, at least four different insertion lines were tested.
Fly strains and genetics
Drosophila strains were raised on standard cornmeal-yeast agar
medium at 25C, except for the GMR–GAL4, UAS–G/
REAPER stock, which was raised at room temperature
(20C). Alleles used in this study were as follows: psnC1 and
psnC2 from Struhl (35); nct J2, nct J1 and nct A7 from Fortini
(33); GMR–G/REAPER (45) from Nambu; GMR–P35 (38)
and GMR-DIAP1 (44).
Flies carrying one copy of GMR–APP–GAL4 and one copy
of UAS–GRIM on the same chromosome were generated by
meiotic recombination. The resulting GMR–APP–GAL4,
UAS–GRIM chromosome was balanced over CyO. GMR–
APP–GAL4, UAS–GRIM flies were crossed into different
genetic backgrounds and the appropriate progeny compared
with the progeny of GMR–APP–GAL4, UAS–GRIM out-
crossed to w 1118, the background stock into which the GMR-
driven transgenes were introduced. Similar crosses were carried
out with the two false positive reporters, GMR–GRIM and
GMR–GAL4, UAS–G/RPR. All crosses were carried out at
25C, except those involving GMR–GAL4, UAS–G/RPR,
which were carried out at room temperature (20C).
A group of stocks (the deficiency kit) that together delete,
one piece at a time, a large fraction of the second chromosome,
was obtained from the Bloomington Stock Center. These lines
were crossed to reporter flies. Reporter progeny carrying one
copy of the deficiency chromosome were examined for
2676 Human Molecular Genetics, 2003, Vol. 12, No. 20
suppression of the reporter small eye phenotype. Those
deficiencies that tested positive in this assay were further
characterized in similar crosses to the false positive reporter
strains GMR–GRIM and GMR–GAL4, UAS–G/RPR.
Scanning electron microscopy
For some samples flies were dehydrated in an ethanol series,
incubated overnight in hexamethyldisilazane (Sigma), and air
dried prior to being analyzed using a Hitachi scanning electron
microscopy. For others, flies were quickly frozen at 80C,
then mounted and analyzed directly. Both methods of
preparation gave identical results.
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